NCT01392352 2020-02-13
HYPAZ
Cambridge University Hospitals NHS Foundation Trust
Phase 2 Terminated
Clinical Trials
8 trialsNCT01503372 2019-02-12
PaFLO
Charite University, Berlin, Germany
Phase 2 Completed
NCT01855724 2018-11-07
Clinical Trial to Investigate the Efficacy of Treatment With Gemcitabine/Pazopanib in Patients With Biliary Tree Cancer
Hellenic Cooperative Oncology Group
Phase 2 Terminated
NCT02342600 2017-10-12
SARC029: Trametinib and Pazopanib in Patients With GIST (Gastrointestinal Stromal Tumor)
Sarcoma Alliance for Research through Collaboration
Phase 2 Withdrawn
NCT01524848 2017-05-10
PAGIST
Scandinavian Sarcoma Group
Phase 2 Completed
NCT01391611 2017-04-07
Pazopanib in Imatinib Refractory or Intolerant Gastrointestinal Stromal Tumors (GIST)
Stanford University
Phase 2 Terminated
NCT01130805 2016-04-15
A Study of Pazopanib With CAPEOX in AGC Patients
Samsung Medical Center
Phase 2 Completed
NCT01080248 2015-06-09
Gemcitabine and Pazopanib in Metastatic Pancreatic Cancer
Washington University School of Medicine
Phase 2 Terminated